Resources from the same session
Use of chemotherapy near the end of life for solid cancers: What factors matter?
Presenter: Philippe Rochigneux
Session: Supportive and palliative care
Resources:
Abstract
Unsung heroes of lung cancer: Perspectives from caregivers in the lung cancer Canada survey
Presenter: Mark Doherty
Session: Supportive and palliative care
Resources:
Abstract
Risk of serious adverse events (SAEs) and fatal adverse events (FAEs) with sorafenib use in patients with solid cancers: a meta-analysis of phase 3 RCTs
Presenter: Bishal Gyawali
Session: Supportive and palliative care
Resources:
Abstract
Psychological discomfort among operatives in oncology: Can burn-out be considered the main issue?
Presenter: Marco Romeo
Session: Supportive and palliative care
Resources:
Abstract
Pooled analysis of treatment-related hypothyroidism with anti-PD-1/PD-L1 therapies in cancer patients
Presenter: Shaodong Hong
Session: Supportive and palliative care
Resources:
Abstract
Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-neulasta® in the prophylaxis of chemotherapy-induced neutropenia
Presenter: Cornelius Waller
Session: Supportive and palliative care
Resources:
Abstract
ONO-7643/anamorelin for the treatment of patients with non-small cell lung cancer and cachexia: results from phase 2 study with Japanese patients
Presenter: Junji Uchino
Session: Supportive and palliative care
Resources:
Abstract
Invited discussant abstracts 1349PD, 1350PD and LBA49
Presenter: Florian Strasser
Session: Supportive and palliative care
Resources:
Presentation
Webcast
Invited discussant abstracts 1301PD, 1436PD, 1437PD, 1438PD, 1439PD and LBA50
Presenter: Bernardo Rapoport
Session: Supportive and palliative care
Resources:
Presentation
Webcast
Invited discussant abstracts 1300O and 1433O
Presenter: Stein Kaasa
Session: Supportive and palliative care
Resources:
Presentation
Webcast